Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.48 -0.20 (-5.43%)
As of: Oct 1, 2026 · 10:46 AM EDT

Bolt Biotherapeutics (BOLT) Non-Current Deffered Revenue (2021 - 2026)

Updated

Bolt Biotherapeutics (BOLT) reported Non-Current Deffered Revenue of $1.17 million for Q2 2026, down 54.7% from $2.59 million a year earlier and down 13.3% from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

At the end of FY2025, Bolt Biotherapeutics posted Non-Current Deffered Revenue of $1.54 million, down 57.3% from FY2024.

  • Non-Current Deffered Revenue has declined for four consecutive years, with a four-year compound annual growth rate of -42.6% (FY2021 to FY2025).
  • By year, Non-Current Deffered Revenue came in at $3.62 million in FY2024 (-60.3%), $9.11 million in FY2023 (-29.5%), $12.92 million in FY2022 (-9.1%) and $14.21 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Non-Current Deffered Revenue in data going back to Q2 2021.
  • Year over year, Non-Current Deffered Revenue has now declined in each of the last 16 quarters, with an average decline of 53.1% over the last eight quarters.
  • The high point for year-over-year Non-Current Deffered Revenue in five years was Q2 2022 (growth of 48.8%); the low point was Q2 2024 (a decline of 62.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.35 million (Q1 2026), $1.54 million (Q4 2025) and $1.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bolt Biotherapeutics 7.09 Mn 7.09 Mn - 1.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.17 Mn
Mar 31, 2026 1.35 Mn
Dec 31, 2025 1.54 Mn
Sep 30, 2025 1.96 Mn
Jun 30, 2025 2.59 Mn
Mar 31, 2025 3.05 Mn
Dec 31, 2024 3.62 Mn
Sep 30, 2024 3.87 Mn
Jun 30, 2024 4.52 Mn
Mar 31, 2024 5.33 Mn
Dec 31, 2023 9.11 Mn
Sep 30, 2023 10.13 Mn
Jun 30, 2023 12.01 Mn
Mar 31, 2023 12.63 Mn
Dec 31, 2022 12.92 Mn
Sep 30, 2022 11.83 Mn
Jun 30, 2022 12.70 Mn
Mar 31, 2022 13.58 Mn
Dec 31, 2021 14.21 Mn
Sep 30, 2021 12.21 Mn
API Access

Bolt Biotherapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BOLT&period=max&api_key=YOUR_API_KEY